digoxin and Persistent-Fetal-Circulation-Syndrome

digoxin has been researched along with Persistent-Fetal-Circulation-Syndrome* in 2 studies

Reviews

1 review(s) available for digoxin and Persistent-Fetal-Circulation-Syndrome

ArticleYear
Patent ductus arteriosus in the neonate.
    Pediatric clinics of North America, 1986, Volume: 33, Issue:3

    Recently there has been a significant reappraisal of the role of PDA in the context of neonatal cardiopulmonary disease. This article reviews surgical intervention, pharmacologic treatment, and assessment of ductal patency in the neonate.

    Topics: Alprostadil; Blood Circulation; Clinical Trials as Topic; Digoxin; Ductus Arteriosus; Ductus Arteriosus, Patent; Heart Defects, Congenital; Heart Function Tests; Humans; Indomethacin; Infant, Newborn; Infant, Premature, Diseases; Ligation; Persistent Fetal Circulation Syndrome; Prostaglandin Antagonists; Random Allocation; Respiratory Distress Syndrome, Newborn

1986

Trials

1 trial(s) available for digoxin and Persistent-Fetal-Circulation-Syndrome

ArticleYear
Patent ductus arteriosus in the neonate.
    Pediatric clinics of North America, 1986, Volume: 33, Issue:3

    Recently there has been a significant reappraisal of the role of PDA in the context of neonatal cardiopulmonary disease. This article reviews surgical intervention, pharmacologic treatment, and assessment of ductal patency in the neonate.

    Topics: Alprostadil; Blood Circulation; Clinical Trials as Topic; Digoxin; Ductus Arteriosus; Ductus Arteriosus, Patent; Heart Defects, Congenital; Heart Function Tests; Humans; Indomethacin; Infant, Newborn; Infant, Premature, Diseases; Ligation; Persistent Fetal Circulation Syndrome; Prostaglandin Antagonists; Random Allocation; Respiratory Distress Syndrome, Newborn

1986

Other Studies

1 other study(ies) available for digoxin and Persistent-Fetal-Circulation-Syndrome

ArticleYear
Use of cardiotonic therapy in the management of infants with PPHN.
    Clinics in perinatology, 1984, Volume: 11, Issue:3

    The author describes the rational use of cardiotonic agents in those infants with PPHN in whom myocardial dysfunction and/or extremely abnormal systemic vascular resistance have been completely documented.

    Topics: Animals; Animals, Newborn; Cardiotonic Agents; Digitalis; Digoxin; Dobutamine; Dogs; Dopamine; Drug Therapy, Combination; Humans; Infant, Newborn; Isoproterenol; Persistent Fetal Circulation Syndrome; Plants, Medicinal; Plants, Toxic; Sheep; Swine

1984